In this episode of #ExpertAnswers, Dr. Sam Sternberg from Columbia University answers questions from a recent webinar discussing a novel CRISPR-Cas9 system using programmable, RNA-guided transposase and highlighting its implications for genome engineering in cell and gene therapies.

For more information or to watch the webinar, click here.